Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats

Depression and the Dynamics of Smoking

Robert F. Anda · JAMA · 1990 · 882 citations

Public Health, Health Sciences, Clinical Epidemiology +15

The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK

Kirstin Pirie, Richard Peto, Gillian Reeves et al. · The Lancet · 2012 · 836 citations · Full text

Public Health, Population Health Sciences, Preventive Medicine +13

Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala

Daniel Huber, Pierre Veinante, Ron Stoop · Science · 2005 · 804 citations

Life Sciences, Neurobiology, Neuroscience +17

Dramatic decreases in brain reward function during nicotine withdrawal

Mark P. Epping-Jordan, Shelly S. Watkins, George F. Koob et al. · Nature · 1998 · 677 citations

Medicine, Neuroscience, Pharmacology +16

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study

Alewijn Ott, AJC Slooter, Albert Hofman et al. · The Lancet · 1998 · 539 citations

Medicine, Geriatric Medicine, Neurology +14